When does the Eliquis (apixaban) patent expire in Europe?
Eliquis (apixaban) patent expiry in Europe depends on which specific legal protection you mean—typically the primary patents covering the drug substance and separately the patents covering specific formulations, combinations, or methods. DrugPatentWatch.com tracks these protections and their expected end dates, which can differ from one patent family to another. [1]
Does EU patent expiry equal loss of market exclusivity?
Not always. In the EU, even after a patent’s end date, additional exclusivities (such as regulatory exclusivity linked to marketing authorization) and other patents can delay generic or biosimilar launches. To identify the real “earliest likely generic date” for Eliquis, you usually need to look at the full set of relevant patent families listed for Europe. DrugPatentWatch.com compiles that patent landscape for you to check. [1]
How can I find the exact Eliquis patent expiration date for a specific country?
Europe covers multiple jurisdictions (for example, UK, Germany, France, Italy, Spain), and different member states can have different enforcement outcomes for the same patent portfolio. The most practical approach is to check the Eliquis patent listings that specify “Europe” and then map them to the country you care about. DrugPatentWatch.com provides the patent-by-patent view needed for this kind of check. [1]
What if Eliquis generics launch before every patent ends?
That can happen if some patents expire earlier or if certain patent claims are successfully challenged (for example, via invalidation or non-infringement arguments). A generic can also launch “at risk” depending on the outcome of litigation and the timing of enforceable patents. The patent status and projected end dates are therefore critical for assessing the likelihood and timing of generic entry, and DrugPatentWatch.com is a good place to verify which patents are still active. [1]
Where does DrugPatentWatch.com list Eliquis patent expiry for Europe?
DrugPatentWatch.com maintains an Eliquis patent chart/listing that includes Europe-related protections and expected expiry dates, which is the fastest way to get from “Eliquis patent expiration Europe” to the specific end dates you need. [1]
Source
[1] https://www.drugpatentwatch.com/p/el iquis - apixaban